Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors
Completed · Not applicable
Conditions studied: Cancer Survivor, Pediatric Cancer
In brief
Survivors of childhood cancer have an increased risk of death from cardiovascular disease due to both the therapies they received while undergoing treatment and diet and lifestyle factors. The nature of cardiovascular risk and the interaction between treatment affects and cardiovascular risk factors is unknown. We propose to study vascular inflammatory markers as well as measure of blood vessel stiffness (both of which are predictive of early heart disease) in 100 pediatric cancer survivors and 100 control children. Characterization of vascular inflammation and stiffness in long-term survivors will allow for the development of future interventions to decrease inflammation through both pharmacologic and lifestyle modifications.
Key facts
- Study ID
- NCT02032121
- Run by
- University of Miami
- People needed
- 6
- Starts
- 2007-10-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2015-09-09
Who can join
Age: 6 and older, up to 30. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 6-30 years of age
- 2 years from the completion of therapy for cancer
- free of active disease
You may not qualify if…
- <6 or > 30 years of age
- current cancer treatment or inside of 2 years post treatment
- Active disease/infection
Where it is running
- University of Miami, MIller School of Medicine — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.